Pegaptanib ophthalmic injection Side Effects

Please note - some side effects for Pegaptanib ophthalmic injection may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Side Effects by Body System - for Healthcare Professionals

Applies to: intraocular solution

Ocular

Ocular side effects classified as serious have included endophthalmitis, retinal detachment, and iatrogenic traumatic cataract in <1% of patients. Anterior chamber inflammation, blurred vision, cataract, conjunctival hemorrhage, corneal edema, eye discharge, eye irritation, eye pain, hypertension, increased intraocular pressure, ocular discomfort, punctate keratitis, reduced visual acuity, visual disturbance, vitreous floaters, and vitreous opacities have been reported in 10% to 40% of patients. Blepharitis, conjunctivitis, photopsia, and vitreous disorder have been reported in 6% to 10% of patients. Allergic conjunctivitis, conjunctival edema, corneal abrasion, corneal deposits, corneal epithelium disorder, eye inflammation, eye swelling, eyelid irritation, meibomianitis, mydriasis, periorbital hematoma, retinal edema, and vitreous hemorrhage have been reported in 1% to 5% of patients.

Respiratory

Respiratory side effects have included bronchitis (6% to 10%) and pleural effusion (1% to 5%) of patients.

Gastrointestinal

Gastrointestinal side effects have included diarrhea (6% to 10%), nausea (6% to 10%), vomiting (1% to 5%), and dyspepsia (1% to 5%).

Nervous system

Nervous system side effects have included dizziness (6% to 10%), headache (6% to 10%), and hearing loss (1% to 5%).

Musculoskeletal

Musculoskeletal side effects have included arthritis, bone spur, and contusion in 1% to 5% of patients.

Cardiovascular

Cardiovascular side effects have included carotid artery occlusion, cerebrovascular accident, chest pain, and transient ischemic attack in 1% to 5% of patients.

Dermatologic

Dermatologic side effects have included contact dermatitis in 1% to 5% of patients.

Genitourinary

Genitourinary side effects have included urinary tract infection (6% to 10%) and urinary retention (1% to 5%).

Metabolic

Metabolic side effects have included diabetes mellitus in 1% to 5% of patients.

Hypersensitivity

Hypersensitivity side effects have rarely included anaphylaxis and/or anaphylactoid reactions, including angioedema. However, causality has not been established.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.